155 related articles for article (PubMed ID: 24396425)
1. Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection.
Takamaru T; Kutomi G; Satomi F; Shima H; Ohno K; Kameshima H; Suzuki Y; Ohmura T; Takamaru H; Nojima M; Mori M; Hirata K
Exp Ther Med; 2014 Feb; 7(2):456-460. PubMed ID: 24396425
[TBL] [Abstract][Full Text] [Related]
2. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
[TBL] [Abstract][Full Text] [Related]
3. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
6. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
[TBL] [Abstract][Full Text] [Related]
9. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.
Veronesi U; Paganelli G; Viale G; Luini A; Zurrida S; Galimberti V; Intra M; Veronesi P; Maisonneuve P; Gatti G; Mazzarol G; De Cicco C; Manfredi G; Fernández JR
Lancet Oncol; 2006 Dec; 7(12):983-90. PubMed ID: 17138219
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors for Unnecessary Axillary Dissection According to SLN Metastasis in T1, T2 Stage Breast Cancer.
Benli S; Aksoy SÖ; Sevinç Aİ; Durak MG; Baysan C
Indian J Surg Oncol; 2022 Dec; 13(4):817-823. PubMed ID: 36687257
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer.
Fujii T; Yajima R; Tatsuki H; Suto T; Morita H; Tsutsumi S; Kuwano H
Anticancer Res; 2015 Jun; 35(6):3581-4. PubMed ID: 26026130
[TBL] [Abstract][Full Text] [Related]
13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
15. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
[TBL] [Abstract][Full Text] [Related]
17. Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma.
Jaka RC; Zaveri SS; Somashekhar SP; Sureshchandra ; Parameswaran RV
Indian J Surg Oncol; 2010 Jan; 1(1):27-36. PubMed ID: 22930615
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated With Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer.
Abdulla HA; Salman AZ; Alaraibi SJ; Nazzal K; Ahmed SA; Almahari SA; Dhaif A
Eur J Breast Health; 2023 Jul; 19(3):229-234. PubMed ID: 37415656
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 246 sentinel lymph node biopsies of patients with clinical primary breast cancer by application of carbon nanoparticle suspension.
Yang SX; Wei WS; Jiang QH; Zhou YF; Qu W; Tu JH; Ou-Yang QW; Zhou ZB; Ding HL; Xie CW
J Obstet Gynaecol Res; 2018 Jun; 44(6):1150-1157. PubMed ID: 29673015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
